Skip to content

Clinical trial of DNA methylation detection kit for urothelial carcinoma

Clinical trial of DNA methylation detection kit for urothelial carcinoma

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046651
Enrollment
Unknown
Registered
2021-05-25
Start date
2021-03-22
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urothelial Carcinoma

Interventions

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Any male or female patient aged 18 or older.; 2. Understand the purpose of the clinical trial and sign the informed consent; 3. Meet one of the following conditions: (1) Patients with urothelial carcinoma or benign diseases of the urinary system or other malignant tumors of the urinary system other than urothelial carcinoma with symptoms of hematuria (intermittent, painless whole-course gross hematuria and microscopic hematuria) and/or bladder irritation (frequent, urgent and painful urination); (2) Patients with non-urinary malignancy; (3) Volunteers without symptoms of urinary system diseases (no obvious abnormalities in routine uronoscopy and Type B ultrasonic). 4. The above-mentioned urothelial carcinoma, benign diseases of the urinary system, other malignancies of the urinary system, non-urinary malignancies and volunteers without symptoms of urinary system diseases had no complicated other malignancies, and no history of other malignancies; 5. Urine samples from patients with malignant tumors should be collected according to tumor load state and preoperative (including radical resection, partial resection, endoscopic surgery or biopsy, etc.), and the samples collected should meet the requirements of the program samples; 6. Enrolled patients should be outpatients or inpatients with pathological diagnosis and/or clinical diagnosis and with complete case information.

Exclusion criteria

Exclusion criteria: 1. The sample does not meet the requirements of the research plan; 2. Incomplete pathological diagnosis and clinical diagnosis information or no definite diagnosis results can be obtained; 3. The situation that other researchers consider unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
DNA methylation;

Countries

China

Contacts

Public ContactHuang Jian

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

hjgcp2017@163.com+86 13600054833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026